Comparison between Enzyme Immunoassays Performed on Samples of Dried Blood and Serum for Toxoplasmosis Prenatal Screening: Population-based Study

Abstract

Objective Most prenatal screening programs for toxoplasmosis use immunoassays in serum samples of pregnant women. Few studies assess the accuracy of screening tests in dried blood spots, which are of easy collection, storage, and transportation. The goals of the present study are to determine the performance and evaluate the agreement between an immunoassay of dried blood spots and a reference test in the serum of pregnant women from a population-based prenatal screening program for toxoplasmosis in Brazil.

Methods A cross-sectional study was performed to compare the immunoassays Imunoscreen Toxoplasmose IgM and Imunoscreen Toxoplasmose IgG (Mbiolog Diagnósticos, Ltda., Contagem, Minas Gerais, Brazil)in dried blood spots with the enzyme-linked fluorescent assay (ELFA, BioMérieux S.A., Lyon, France) reference standard in the serum of pregnant women from Minas Gerais Congenital Toxoplasmosis Control Program.

Results The dried blood spot test was able to discriminate positive and negative results of pregnant women when compared with the reference test, with an accuracy of 98.2% for immunoglobulin G (IgG), and of 95.8% for immunoglobulin M (IgM).

Conclusion Dried blood samples are easy to collect, store, and transport, and they have a good performance, making this a promising method for prenatal toxoplasmosis screening programs in countries with continental dimensions, limited resources, and a high prevalence of toxoplasmosis, as is the case of Brazil.

Resumo

Objetivo A maioria dos programas de triagem pré-natal para toxoplasmose utiliza imunoensaios em amostras de soro de gestantes. Poucos estudos avaliam a acurácia dos testes de triagem em amostras de sangue seco, que são de fácil coleta, armazenamento e transporte. Este estudo teve como objetivo determinar o desempenho e avaliar a concordância entre um imunoensaio em sangue seco e um teste de referência em soro de gestantes de um programa de rastreamento pré-natal de base populacional para toxoplasmose no Brasil.

Métodos Realizou-se um estudo transversal para comparar os imunoensaios Imunoscreen Toxoplasmose IgM e Imunoscreen Toxoplasmose IgG (Mbiolog Diagnósticos, Ltda., Contagem, Minas Gerais, Brazil) em sangue seco com o padrão de referência ensaio fluorescente ligado a enzimas (enzyme-linked fluorescent assay, ELFA, BioMérieux S.A., Lion, França) no soro de gestantes do Programa de Controle de Toxoplasmose Congênita de Minas Gerais.

Resultados O exame em sangue seco foi capaz de discriminar os resultados positivos e negativos das gestantes quando comparado ao teste de referência, com acurácia de 98,2% para imunoglobulina G (IgG), e de 95,8% para imunoglobulina M (IgM).

Conclusão O sangue seco apresenta bom desempenho e é uma amostra de fácil coleta, armazenamento e transporte, o que o torna um método promissor para programas de triagem pré-natal de toxoplasmose em países com dimensões continentais, recursos limitados, e alta prevalência de toxoplasmose, como é o caso do Brasil.

Keywords

prenatal care - prenatal diagnosis - dried blood spot testing - toxoplasmosis - congenital toxoplasmosis

Palavras-chave

cuidado pré-natal - diagnóstico pré-natal - teste em amostras de sangue seco - toxoplasmose - toxoplasmose congênita

Contributors

All of the authors contributed to the project and data interpretation, the writing of the article, the critical review of the intellectual content, and approved the final version to be published.

Publikationsverlauf

Eingereicht: 23. Februar 2020

Angenommen: 12. Februar 2021

Artikel online veröffentlicht:
02. Juni 2021

• References

• 1 Figueiró-Filho EA, Lopes AHA, Seneforte FRA, de Souza Júnior VG, Botelho CA, Figueiredo MS, Duarte G. [Acute toxoplasmosis: study of the frequency, vertical transmission rate and the relationship between maternal-fetal diagnostic tests during pregnancy in a Central-Western state of Brazil]. Rev Bras Ginecol Obstet 2005; 27 (08) 442-449
• 2 Sartori AL, Minamisava R, Avelino MM, Martins CA. [Prenatal screening for toxoplasmosis and factors associated with seropositivity of pregnant women in Goiânia, Goiás]. Rev Bras Ginecol Obstet 2011; 33 (02) 93-98
• 3 Amaral E. [A population screening program for toxoplasmosis?]. Rev Bras Ginecol Obstet 2005; 27 (08) 439-441
• 4 Marques BA, Andrade GMQ, Neves SPF, Pereira FH, Talim MCT. [Systematic review of serological methods used in prenatal screening for toxoplasmosis in pregnant women]. Rev Med Minas Gerais. 2015; 25 (Suppl. 06) S68-S81
• 5 Couto JCF, Avelino MM, Ferreira QTM. [Toxoplasmosis: toxoplasmosis and pregnancy]. In: Couto LCF, Andrade GM, Tonelli E. [Perinatal infections]. Rio de Janeiro: Guanabara Koogan; 2006: 471-492
• 6 Peyron F, Wallon M, Kieffer F, Garweg J. Toxoplasmosis. In: Wilson CB, Nizet V, Maldonado YA, Remington JS, Klein JO. editors. Remington and Klein's infectious diseases of the fetus and newborn infant. 8th ed.. Philadelphia: Elsevier Saunders; 2015: 949-1042
• 7 Brito C, Portela MC, de Vasconcellos MT. [Clinical and demographic data concordance comparing authorizations for high-complexity oncological procedures and patient records of women treated under the Unified National Health System in Rio de Janeiro, Brazil]. Cad Saude Publica 2005; 21 (06) 1829-1835
• 8 Carellos EVM, Andrade GMQ, Aguiar RALP. [Evaluation of prenatal screening for toxoplasmosis in Belo Horizonte, Minas Gerais State, Brazil: a cross-sectional study of postpartum women in two maternity hospitals]. Cad Saude Publica 2008; 24 (02) 391-401
• 9 Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 2012; 139 (11) 1375-1424
• 10 Avelino MM, Parada JCB, Castro AM, Alves MFC, Campos Júnior D. Toxoplasma gondii primary infection in pregnant women in Goiânia: a seroconversion study. Rev Ciênc Méd Biol 2009; 8 (03) 325-333
• 11 Varella IS, Canti ICT, Santos BR, Coppini AZ, Argondizzo LC, Tonin C, Wagner MB. Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil. Mem Inst Oswaldo Cruz 2009; 104 (02) 383-388
• 12 Boa-Sorte N, Purificação A, Amorim T, Assunção L, Reis A, Galvão-Castro B. Dried blood spot testing for the antenatal screening of HTLV, HIV, syphilis, toxoplasmosis and hepatitis B and C: prevalence, accuracy and operational aspects. Braz J Infect Dis 2014; 18 (06) 618-624
• 13 Martinez EZ, Louzada Neto F, Pereira BB. [Analysis of diagnostic tests using ROC curves]. Cad Saude Colet 2003; 11 (01) 7-31
• 14 Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, Remington JS. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 1997; 35 (01) 174-178
• 15 Flori P, Chene G, Varlet MN, Sung RT. [Toxoplasma gondii serology in pregnant woman: characteristics and pitfalls]. Ann Biol Clin (Paris) 2009; 67 (02) 125-133
• 16 Hoehler FK. Bias and prevalence effects on kappa viewed in terms of sensitivity and specificity. J Clin Epidemiol 2000; 53 (05) 499-503